Current use of biologic therapies for musculoskeletal disease: A survey of board-certified equine specialists.

ABSTRACT:

Objective

To evaluate the use of mesenchymal stem cells (MSCs), autologous conditioned serum (ACS), platelet-rich plasma (PRP), and autologous protein solution (APS) for the treatment of equine musculoskeletal disease by diplomates of the American College of Veterinary Surgery (ACVS), and American College of Veterinary Sports Medicine and Rehabilitation (ACVSMR).

Study design

Cross-sectional study.

Sample population

Diplomates (n = 423).

Methods

An email link was sent to ACVS and ACVMR diplomates. A survey contained 59 questions regarding demographics, as well as indications, frequency, adverse effects, and limitations of use. Responses were analyzed using Fisher's exact test.

Results

One hundred and fifty four surveys were analyzed. Years in practice an

SUBMITTER: Knott LE 

PROVIDER: S-EPMC9322007 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature